The Role of Glial Fibrillary Acidic Protein in the Neuropathology of Alzheimer’s Disease and Its Potential as a Blood Biomarker for Early Diagnosis and Progression. Here, GFAP is linked to early-onset autosomal dominant Alzheimer disease.